Navigating University Life with a Chronic Illness
We asked students with chronic illness what helped them in their journey.
How to Talk with Your Doctor About Your LGBTQ+ Identity
Finding a doctor who makes you feel safe to share your identity is key to getting the best care. Here are some patient and provider tips to help you get started.
How Gender-Affirming Hormone Therapy Affects Chronic Disease
It can feel isolating when you face pushback or lack of knowledge from providers, but know that you’re not alone in advocating for your best care.
Navigating Insurance and Health Care Rights for LGBTQ+ Patients
It can feel isolating when you face pushback or lack of knowledge from providers, but know that you’re not alone in advocating for your best care.
6 Common Myths About Hidradenitis Suppurativa (HS) That May Harm Patients
Myths about hidradenitis suppurativa (HS) may be harmful to those who suspect they may have it or who are already living with it. Get the facts about this chronic skin condition.
ChronicHue: Bringing Mental Health Support to the BIPOC Chronic Illness Community
ChronicHue provides a much-needed virtual platform for BIPOC patients to share experiences and receive support for better mental health.
Popular ArthritisPower® Patient Registry Expands Conditions and Becomes PatientSpot™
UPPER NYACK, N.Y.--(BUSINESS WIRE) — ArthritisPower, leading arthritis patient registry, expands to PatientSpot, an omni-disease app as Class 1 FDA Medical Device.
Black History, Patient Voices: Advocating for Equity Beyond February
"Black history is not confined to a single month; the same goes for health equity — it is a continuous narrative that should be woven into the fabric of our health care systems year-round." — Michelle Walters-Johnson, patient advocate
FDA Approves Zepbound for Obesity
Learn more about the FDA approval of new drug, Zepbound (tripeptide), for the treatment of adults with obesity.
FDA Approves Omvoh for Ulcerative Colitis
Learn more about the approval of a new drug, Omvah ((mirikizumab-mrkz), for people with moderately to severely active ulcerative colitis.